Wharton Business Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-5,927
| Closed | -$275K | – | 102 |
|
|
2017
Q4 | $275K | Sell |
5,927
-6,000
| -50% | -$278K | 0.03% | 91 |
|
|
2017
Q3 | $482K | Hold |
11,927
| – | – | 0.05% | 75 |
|
|
2017
Q2 | $404K | Hold |
11,927
| – | – | 0.04% | 87 |
|
|
2017
Q1 | $346K | Hold |
11,927
| – | – | 0.04% | 91 |
|
|
2016
Q4 | $392K | Hold |
11,927
| – | – | 0.05% | 89 |
|
|
2016
Q3 | $376K | Hold |
11,927
| – | – | 0.05% | 96 |
|
|
2016
Q2 | $335K | Hold |
11,927
| – | – | 0.04% | 105 |
|
|
2016
Q1 | $434K | Hold |
11,927
| – | – | 0.05% | 100 |
|
|
2015
Q4 | $477K | Hold |
11,927
| – | – | 0.05% | 100 |
|
|
2015
Q3 | $340K | Hold |
11,927
| – | – | 0.03% | 107 |
|
|
2015
Q2 | $393 | Hold |
11,927
| – | – | 0.03% | 110 |
|
|
2015
Q1 | $343K | Sell |
11,927
-27,500
| -70% | -$791K | 0.03% | 116 |
|
|
2014
Q4 | $1.07M | Sell |
39,427
-7,500
| -16% | -$204K | 0.09% | 95 |
|
|
2014
Q3 | $1M | Buy |
+46,927
| New | +$1M | 0.09% | 101 |
|